Annual Net Margin
-43.11%
+32.29%+42.82%
December 31, 2023
Summary
- As of February 22, 2025, SRPT annual net profit margin is -43.11%, with the most recent change of +32.29% (+42.82%) on December 31, 2023.
- During the last 3 years, SRPT annual net margin has risen by +59.49% (+57.98%).
- SRPT annual net margin is now -774.44% below its all-time high of -4.93%, reached on December 31, 2011.
Performance
SRPT Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Margin
7.19%
+5.41%+303.93%
September 30, 2024
Summary
- As of February 22, 2025, SRPT quarterly net profit margin is 7.19%, with the most recent change of +5.41% (+303.93%) on September 30, 2024.
- Over the past year, SRPT quarterly net margin has dropped by -4.32% (-37.53%).
- SRPT quarterly net margin is now -89.97% below its all-time high of 71.72%, reached on June 30, 2012.
Performance
SRPT Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Margin Formula
Net Margin = Net Income
Revenue ✕ 100%
Revenue ✕ 100%
SRPT Net Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +42.8% | -37.5% |
| 3 y3 years | +58.0% | +106.4% |
| 5 y5 years | +64.1% | +106.4% |
SRPT Net Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +42.8% | -37.5% | +103.5% |
| 5 y | 5-year | at high | +77.0% | -37.5% | +103.0% |
| alltime | all time | -774.4% | +99.8% | -90.0% | +100.0% |
Sarepta Therapeutics Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 7.19%(+303.9%) |
| Jun 2024 | - | 1.78%(-79.6%) |
| Mar 2024 | - | 8.74%(-24.1%) |
| Dec 2023 | -43.11%(-42.8%) | 11.51%(-193.3%) |
| Sep 2023 | - | -12.34%(+34.7%) |
| Jun 2023 | - | -9.16%(-95.5%) |
| Mar 2023 | - | -203.85%(+382.3%) |
| Dec 2022 | -75.40%(+26.4%) | -42.27%(-62.2%) |
| Sep 2022 | - | -111.93%(+12.9%) |
| Jun 2022 | - | -99.14%(+99.0%) |
| Mar 2022 | - | -49.82%(-17.7%) |
| Dec 2021 | -59.66%(-41.9%) | -60.55%(+138.2%) |
| Sep 2021 | - | -25.42%(-48.8%) |
| Jun 2021 | - | -49.61%(-56.4%) |
| Mar 2021 | - | -113.83%(-12.7%) |
| Dec 2020 | -102.60%(-45.4%) | -130.44%(-4.5%) |
| Sep 2020 | - | -136.53%(+24.3%) |
| Jun 2020 | - | -109.80%(+613.5%) |
| Mar 2020 | - | -15.39%(-93.5%) |
| Dec 2019 | -187.77%(+56.2%) | -235.44%(+84.6%) |
| Sep 2019 | - | -127.55%(-56.3%) |
| Jun 2019 | - | -291.97%(+231.5%) |
| Mar 2019 | - | -88.08%(-47.2%) |
| Dec 2018 | -120.23%(+266.7%) | -166.91%(+71.5%) |
| Sep 2018 | - | -97.33%(-34.5%) |
| Jun 2018 | - | -148.60%(+171.5%) |
| Mar 2018 | - | -54.74%(+30.6%) |
| Dec 2017 | -32.79%(-99.3%) | -41.90%(-59.7%) |
| Sep 2017 | - | -103.87%(-42.3%) |
| Jun 2017 | - | -180.07%(-89.0%) |
| Dec 2016 | -4930.18%(-71.9%) | -1631.65%(-68.4%) |
| Dec 2015 | -17.56 K%(+1161.8%) | -5162.09%(-96.9%) |
| Dec 2014 | -1391.71%(+76.7%) | -164.50 K%(+5860.8%) |
| Sep 2014 | - | -2759.77%(+110.4%) |
| Jun 2014 | - | -1311.42%(+182.4%) |
| Mar 2014 | - | -464.41%(+38.3%) |
| Dec 2013 | -787.57%(+142.4%) | -335.87%(-66.7%) |
| Sep 2013 | - | -1008.40%(+56.2%) |
| Jun 2013 | - | -645.58%(-31.4%) |
| Mar 2013 | - | -940.63%(+11.2%) |
| Dec 2012 | -324.91%(+6490.5%) | -846.06%(+29.3%) |
| Sep 2012 | - | -654.26%(-1012.2%) |
| Jun 2012 | - | 71.72%(-145.4%) |
| Mar 2012 | - | -157.90%(+1421.2%) |
| Dec 2011 | -4.93%(-95.5%) | -10.38%(-80.6%) |
| Sep 2011 | - | -53.43%(-584.0%) |
| Jun 2011 | - | 11.04%(-13.9%) |
| Mar 2011 | - | 12.82%(-126.0%) |
| Dec 2010 | -109.37%(-23.6%) | -49.26%(-41.2%) |
| Sep 2010 | - | -83.81%(-79.9%) |
| Jun 2010 | - | -416.71%(+759.9%) |
| Mar 2010 | - | -48.46%(-170.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2009 | -143.07%(+27.0%) | 68.62%(-153.9%) |
| Sep 2009 | - | -127.34%(-80.9%) |
| Jun 2009 | - | -667.84%(+2169.2%) |
| Mar 2009 | - | -29.43%(+41.4%) |
| Dec 2008 | -112.68%(-54.4%) | -20.82%(-82.2%) |
| Sep 2008 | - | -116.95%(+232.8%) |
| Jun 2008 | - | -35.14%(-86.8%) |
| Mar 2008 | - | -266.93%(+235.4%) |
| Dec 2007 | -247.31%(-99.1%) | -79.58%(-67.1%) |
| Sep 2007 | - | -241.63%(-33.4%) |
| Jun 2007 | - | -363.04%(-80.0%) |
| Mar 2007 | - | -1813.85%(-96.2%) |
| Dec 2006 | -26.95 K%(+7631.7%) | -48.32 K%(+2.4%) |
| Sep 2006 | - | -47.17 K%(+26.8%) |
| Jun 2006 | - | -37.19 K%(+170.7%) |
| Mar 2006 | - | -13.74 K%(+4177.9%) |
| Dec 2005 | -348.59%(-93.9%) | -321.11%(+522.7%) |
| Sep 2005 | - | -51.57%(-99.6%) |
| Jun 2005 | - | -12.55 K%(+3.1%) |
| Mar 2005 | - | -12.17 K%(+596.4%) |
| Dec 2004 | -5756.08%(+281.9%) | -1747.36%(-96.9%) |
| Sep 2004 | - | -55.81 K%(+183.2%) |
| Jun 2004 | - | -19.71 K%(+160.2%) |
| Mar 2004 | - | -7574.09%(+230.7%) |
| Dec 2003 | -1507.08%(-57.0%) | -2290.43%(+106.2%) |
| Sep 2003 | - | -1111.05%(-48.4%) |
| Jun 2003 | - | -2153.76%(+62.5%) |
| Mar 2003 | - | -1325.52%(-43.8%) |
| Dec 2002 | -3508.56%(-8.0%) | -2360.34%(-22.3%) |
| Sep 2002 | - | -3036.83%(-42.8%) |
| Jun 2002 | - | -5310.24%(+61.5%) |
| Mar 2002 | - | -3288.29%(+110.9%) |
| Dec 2001 | -3813.21%(+435.4%) | -1559.13%(-69.3%) |
| Sep 2001 | - | -5071.12%(+24.8%) |
| Jun 2001 | - | -4063.55%(-79.6%) |
| Mar 2001 | - | -19.89 K%(+65.3%) |
| Dec 2000 | -712.22%(-91.4%) | -12.03 K%(+552.8%) |
| Sep 2000 | - | -1842.74%(-88.2%) |
| Jun 2000 | - | -15.56 K%(>+9900.0%) |
| Mar 2000 | - | -100.71%(-95.8%) |
| Dec 1999 | -8300.00%(-68.9%) | -2400.02%(-100.0%) |
| Sep 1999 | - | -220.00 M%(>+9900.0%) |
| Jun 1999 | - | -2000.00%(+17.6%) |
| Mar 1999 | - | -1700.00%(-92.0%) |
| Dec 1998 | -26.70 K%(+641.7%) | - |
| Sep 1998 | - | -21.30 K%(+1152.9%) |
| Jun 1998 | - | -1700.00%(+21.4%) |
| Mar 1998 | - | -1400.00%(+55.6%) |
| Dec 1997 | -3600.00%(+71.4%) | - |
| Sep 1997 | - | -900.00%(-30.8%) |
| Jun 1997 | - | -1300.00%(+333.3%) |
| Mar 1997 | - | -300.00% |
| Dec 1996 | -2100.00% | - |
FAQ
- What is Sarepta Therapeutics annual net profit margin?
- What is the all time high annual net margin for Sarepta Therapeutics?
- What is Sarepta Therapeutics annual net margin year-on-year change?
- What is Sarepta Therapeutics quarterly net profit margin?
- What is the all time high quarterly net margin for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly net margin year-on-year change?
What is Sarepta Therapeutics annual net profit margin?
The current annual net margin of SRPT is -43.11%
What is the all time high annual net margin for Sarepta Therapeutics?
Sarepta Therapeutics all-time high annual net profit margin is -4.93%
What is Sarepta Therapeutics annual net margin year-on-year change?
Over the past year, SRPT annual net profit margin has changed by +32.29% (+42.82%)
What is Sarepta Therapeutics quarterly net profit margin?
The current quarterly net margin of SRPT is 7.19%
What is the all time high quarterly net margin for Sarepta Therapeutics?
Sarepta Therapeutics all-time high quarterly net profit margin is 71.72%
What is Sarepta Therapeutics quarterly net margin year-on-year change?
Over the past year, SRPT quarterly net profit margin has changed by -4.32% (-37.53%)